格隆汇6月9日丨根据联交所最新权益披露资料显示,2025年6月5日,泰格医药(03347.HK)获兴证全球基金管理有限公司在场内以每股均价35.2311港元增持46.92万股,涉资约1653.04万港元。
增持后,兴证全球基金管理有限公司最新持股数目为7,434,015股,持股比例由5.66%上升至6.04%。
格隆汇6月9日丨根据联交所最新权益披露资料显示,2025年6月5日,泰格医药(03347.HK)获兴证全球基金管理有限公司在场内以每股均价35.2311港元增持46.92万股,涉资约1653.04万港元。
增持后,兴证全球基金管理有限公司最新持股数目为7,434,015股,持股比例由5.66%上升至6.04%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.